Ravi Penmetsa
Corporate Officer/Principal at International Society for Pharmaceutical Engineering
Profile
Ravi Penmetsa is currently a member of the International Society for Pharmaceutical Engineering.
He was previously the Vice Chairman & Managing Director at Gland Pharma Ltd.
Penmetsa holds a doctorate degree from both East Carolina University and Osmania University.
Ravi Penmetsa active positions
| Companies | Position | Start |
|---|---|---|
International Society for Pharmaceutical Engineering
 International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Corporate Officer/Principal | - |
Former positions of Ravi Penmetsa
| Companies | Position | End |
|---|---|---|
| GLAND PHARMA LIMITED | Chief Executive Officer | - |
Training of Ravi Penmetsa
| Osmania University | Doctorate Degree |
| East Carolina University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GLAND PHARMA LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |
- Stock Market
- Insiders
- Ravi Penmetsa
